ZNF331 Represses the Proliferation of Head and Neck Squamous Cell Carcinoma via Co‐Repressor TRIM28
Oral Diseases · 2025
DOI: 10.1111/odi.15209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Ju Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Tripartite Motif-Containing Protein 28, Head and Neck Neoplasms, Repressor Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Youth Innovation Project of Sichuan Medical Association, China.
Abstract (Originalsprache)
Objective
This study aims to explore the regulatory effect of Zinc Finger Protein 331 (ZNF331), a KRAB domain‐containing transcriptional repressor, in Head and Neck Squamous Cell Carcinoma (HNSCC). Materials and Methods Data from The Cancer Genome Atlas (TCGA)‐HNSC were analyzed. The roles of ZNF331 in HNSCC cell proliferation, cell cycle progression, and its interacting proteins were explored through in vitro manipulation of ZNF331 expression and in vivo xenograft experiments. The epigenetic mechanisms underlying ZNF331 dysregulation were investigated by assessing its promoter methylation and the effects of DNA methyltransferase (DNMT) knockdown.
Results
Patients with higher ZNF331 expression had a significantly improved progression‐free interval (PFI). ZNF331 overexpression inhibits HNSCC cell proliferation and induces G2/M arrest, while its knockdown enhances oncogenic features. ZNF331 can downregulate the expression of oncogenes such as DDX5 , EIF5A , and SET . ZNF331's tumor‐suppressive activity requires TRIM28, a universal co‐repressor of KRAB‐ZNF proteins. ZNF331 expression is suppressed by DNMT3B‐mediated promoter hypermethylation. Selective knockdown of DNMT3B , but not DNMT3A , restored ZNF331 expression.
Conclusions
ZNF331 acts as a potential tumor suppressor in HNSCC, whose inactivation through DNMT3B‐mediated hypermethylation may contribute to HNSCC tumorigenesis. Restoring ZNF331 expression through targeted epigenetic therapies may offer a novel strategy for the treatment of HNSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
- Vincent Mary School of Engineering, Science and Technology Assumption University of Thailand, Bangkok, Thailand.
- Department of Medical Aesthetics, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
- School of Chengdu Medical College, Chengdu, Sichuan, China.
- School of Public Health, Southwest Medical University, Luzhou, Sichuan, China.
ORCID-Profile: Yan Li
Förderung
- Youth Innovation Project of Sichuan Medical Association, China
Zitieren
APA
Li, J., Cheng, H., Zhao, Y., Wang, Y., Gong, C., Gong, R., & Li, Y. (2025). ZNF331 Represses the Proliferation of Head and Neck Squamous Cell Carcinoma via Co‐Repressor TRIM28. Oral Diseases. https://doi.org/10.1111/odi.15209
Vancouver
Li J, Cheng H, Zhao Y, Wang Y, Gong C, Gong R, et al. ZNF331 Represses the Proliferation of Head and Neck Squamous Cell Carcinoma via Co‐Repressor TRIM28. Oral Diseases. 2025. doi:10.1111/odi.15209
BibTeX
@article{Li2025,
author = {Li, Ju and Cheng, Hao and Zhao, Yong and Wang, Yunkang and Gong, Chen and Gong, Renguo and Li, Yan},
title = {ZNF331 Represses the Proliferation of Head and Neck Squamous Cell Carcinoma via Co‐Repressor TRIM28},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.15209}
}
EUVIMED